[Cytostatic treatment of hypernephroid renal carcinoma (author's transl)].
Thirty patients with metastasing hypernephroid renal carcinoma were treated with sequential cytostatic combinations of vincristine and ifosfamide (Holoxan¿). Two complete and two partial remissions and arrest of tumour growth in two cases were achieved. These results justify use of at least time-limited chemotherapy so as not to miss a chance of long-term remission in tumour patients.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D001859:Bone Neoplasms / Q000556:secondary; D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use*
D014750:Vincristine; D003520:Cyclophosphamide; D007069:Ifosfamide
Zytostatische Therapie des hypernephroiden Nierenkarzinoms.